InvestorsHub Logo
Followers 26
Posts 6679
Boards Moderated 4
Alias Born 03/20/2017

Re: None

Tuesday, 11/06/2018 1:39:18 PM

Tuesday, November 06, 2018 1:39:18 PM

Post# of 39884
WEED discovery made, human trials start early 2019 with Dr Meiri.
More info in the ANNUAL REPORT and updated news Kgem.
Consider Technions rep as leader in weed science it`s good.

EndoCRO Ltd, Israel, for the formulation of a unique medical Cannabis drug delivery system;

THE TECHNION, Israel. MCRG, our Medical Cannabis Research group, has signed an agreement to fund the research studies of Dr David (Dedi) Meiri Ph.D., and his team as they investigate the intervention of medicinal cannabis to disrupt the debilitating mechanisms of Autoimmune Disease, in particular, Multiple Sclerosis.

MCRG has the rights to an exclusive license agreement to benefit from any discoveries that come as a direct result of the research being conducted by Dr Meiri and his team. The team has already had ground breaking success in the lab in the first 6 months of this research with human trials currently being progressed;

https://www.queenslandbauxite.com/ (QBL become CANN Global the 21 nov)

https://hotcopper.com.au/threads/ann-annual-r...91e1PZFzIU

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.